Recommended Antibiotics for Simple Pneumonia
For simple community-acquired pneumonia in adults, the first-line treatment is oral amoxicillin 3 g/day for pneumococcal pneumonia, or a macrolide (such as azithromycin) for atypical pneumonia. 1
Adult Treatment Algorithm
Outpatient Treatment (Adults)
Suspected pneumococcal pneumonia (especially in adults over 40 years):
Suspected atypical pneumonia (adults under 40 years, within epidemic context):
Alternative when pathogen is uncertain:
Hospitalized Patients (Non-ICU)
- Non-antipseudomonal cephalosporin (ceftriaxone/cefotaxime) + macrolide 1
- OR Respiratory fluoroquinolone (moxifloxacin or levofloxacin) 1
- Duration: 7-8 days in responding patients 1
Severe Pneumonia (ICU)
- No risk for Pseudomonas: Non-antipseudomonal cephalosporin + macrolide OR respiratory fluoroquinolone 1
- Risk for Pseudomonas: Antipseudomonal agent (cephalosporin, acylureidopenicillin/β-lactamase inhibitor, or carbapenem) PLUS ciprofloxacin OR macrolide + aminoglycoside 1
Pediatric Treatment Algorithm
Outpatient Treatment (Children)
Children < 5 years old:
Children ≥ 5 years old:
Hospitalized Children
- Fully immunized: Ampicillin or penicillin G 1
- Not fully immunized: Ceftriaxone or cefotaxime 1
- Add azithromycin if atypical pneumonia suspected 1
Special Considerations
Aspiration Pneumonia
- First-line: Amoxicillin-clavulanate (1-2g PO q12h or 1.2g IV q8h) 6
- Alternatives: Clindamycin + cephalosporin, or moxifloxacin 1, 6
Treatment Monitoring
- Assess clinical response within 48-72 hours 1
- Do not change treatment within first 72 hours unless clinical worsening 1
- Consider treatment failure if no improvement after 72 hours 6
- Measure C-reactive protein on days 1 and 3/4 to assess response 6
Switching from IV to Oral Therapy
- Switch to oral treatment when clinically stable 1
- Early mobilization is recommended for all patients 1
- Low molecular weight heparin should be given to patients with acute respiratory failure 1
Important Caveats
- Antibiotics should NOT be prescribed for acute bronchitis in healthy adults 1
- Macrolides are preferred for atypical pneumonia due to their effectiveness against Mycoplasma, Chlamydia, and Legionella 7
- Recent studies show shorter antibiotic courses (≤7 days) are as effective as longer courses for uncomplicated pneumonia 6
- For penicillin-allergic patients, consider respiratory fluoroquinolones or macrolides 1
- Resistance patterns should be considered when selecting empiric therapy, particularly for S. pneumoniae 8, 5
By following this evidence-based approach to antibiotic selection for simple pneumonia, clinicians can provide effective treatment while minimizing antibiotic resistance and adverse effects.